Q1 FY27 results reported
As filed · Press Release
EarningsMajormateriality 75 out of 100
What happened
FactRPGLIFE has released its unaudited financial results for the quarter ended June 30, 2026. The details are provided in a press release enclosed with the filing. The filing was submitted to both the National Stock Exchange of India and BSE Limited.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedEarlierQ4 FY26
In Q4 FY26, RPG Life Sciences recorded a 23.6% Y-o-Y increase in revenue, along with a healthy EBITDA margin of 25.6%.
NowQ1 FY27
Revenue grew 15.8%, EBITDA by 17.9% and margins by 40 bps y-o-y in Q1 FY27
Change
FactTimeline delay
Implication
CapitSignal interpretationThe stated timeline moved by 1 quarter(s) (earlier to later). The stated figure moved -33.05%.confidence 60%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- On the back of continued robust performance, The Board of Directors has recommended highest ever dividend of 2 (management committed by FY25)
- The Board of Directors at its meeting held today has recommended a Final dividend of Rs 24 per equity share i. (management committed by FY26)
Evidence
- Press Release(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%